Senescent Macrophages Drive Liver Disease and Inflammaging in New Study

This groundbreaking research identifies a specific type of immune cell as a major culprit in age-related disease. As we age, our bodies accumulate senescent cells that secrete inflammatory molecules, contributing to chronic diseases. While scientists knew senescent cells drove aging, the specific cell types responsible remained unclear.

UCLA researchers used advanced molecular profiling to study macrophages - immune cells that normally protect tissues. They exposed mouse and human macrophages to DNA damage and cholesterol stress, finding that these cells can enter a senescent state characterized by p21 and TREM2 protein expression.

These senescent macrophages produce inflammatory molecules through a pathway involving mitochondrial DNA leakage and interferon signaling. The team found these problematic cells accumulate in aging mouse livers and human cirrhotic liver tissue, directly contributing to metabolic dysfunction-associated steatotic liver disease (fatty liver).

Most encouragingly, senolytic drugs that selectively eliminate senescent cells reduced liver inflammation and fat accumulation in both aged mice and those with metabolic liver disease. This suggests targeting senescent macrophages could treat age-related liver problems and potentially other inflammatory conditions.

The findings establish macrophage senescence as a central mechanism driving chronic inflammation in aging, offering a concrete therapeutic target for extending healthspan.